检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵斌[1] 周俊国[1] 蒙根[2] 王钟敏[3] 吕扬[1] 周同惠[1]
机构地区:[1]中国医学科学院,中国协和医科大学药物研究所,北京100050 [2]内蒙医学院化学系,内蒙古呼和浩特010059 [3]河北建工学院基础部,河北张家口075000
出 处:《药学学报》2001年第5期373-376,共4页Acta Pharmaceutica Sinica
摘 要:目的 研究桥环黄皮酰胺差向异构体的结构。方法 用单晶X 射线衍射分析法测定了从植物黄皮提取物中分离得到的化合物I和采用合成方法得到的化合物III的晶体结构 ,并用分子力学计算方法分别模建化合物II和IV的立体结构。结果 化合物I和III的分子式均为C18H17O2 N ,计算分子量为 2 79 34,其中化合物I属单斜晶系 ,空间群为P2 1;化合物III属三斜晶系 ,空间群为P1。结论 化合物I和III均为桥环黄皮酰胺 ,但在C6位苯环的取向不同。桥环黄皮酰胺可形成 4对差向异构体 。AIM To study the structures of the epimerides of cycloclausenamide. METHODS The structures of compound I, extracted from Clausena lansium (Lour.) Skeels, and synthesized compound III were determined by single crystal X ray diffraction analysis. The stereo structures of compound II and IV were also built up through Tripos force field based on crystal structures of compound I and III. RESULTS The molecular formula and molecular weight were found to be C 18 H 17 O 2N and 279 34 respectively. Compound I crystallized in monoclinic system, space group P2 1 with a =0 5928(1), b =1 5014(1), c =1 6190(1) nm, V =1 4410(3) nm 3, Z =4, D x=1 288 g·cm -3 , R f=0 075, R w=0 073( w =1/σ 2|F|), S =3 983; compound III crystallized in triclinic system, space group P1 with a =0 5667(1), b =1 2934(1), c =2 1119(1) nm, α=102 17(1), β=90 25(1), γ=102 65(2)°, V =1 4770(5) nm 3, Z =4, D x=1 224 g·cm -3 , R f=0 047, R w=0 051( w =1/σ 2|F|), S =0 467. CONCLUSION These results showed that compound I and III both are cycloclausenamide except that the directions of the phenyl group on C 6 are different. Cycloclausenamide can form 4 pairs of epimerides but the directions of the phenyl group does not affect their energy in free state.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.42